论文信息 - Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E - 字舞流文

Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E

M. Bhasin | C. Nucera | S. Karumanchi | N. Hsu | G. Roti | A. Lo | C. Bryke | P. Van Hummelen | Z. Antonello | E. Ye | Mukta Joshi | M. Joshi | Agnes Lo | S. A. Karumanchi | Agnes S. Lo | Christine Bryke